Sabe, H., Hashimoto, A., Hashimoto, S., & Oikawa, T. (2016). Tumor responsiveness to statins requires overexpression of the ARF6 pathway. Mol Cell Oncol.
Citación estilo ChicagoSabe, Hisataka, Ari Hashimoto, Shigeru Hashimoto, y Tsukasa Oikawa. "Tumor Responsiveness to Statins Requires Overexpression of the ARF6 Pathway." Mol Cell Oncol 2016.
Cita MLASabe, Hisataka, Ari Hashimoto, Shigeru Hashimoto, y Tsukasa Oikawa. "Tumor Responsiveness to Statins Requires Overexpression of the ARF6 Pathway." Mol Cell Oncol 2016.
Precaución: Estas citas no son 100% exactas.